Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Aurobindo Pharma receives USFDA Approval for Droxidopa Capsules ".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Aurobindo Pharma receives USFDA Approval for Droxidopa Capsules ".